Péter Kisfali

Péter Kisfali

Auto-generated profile, based on publicly available information

Péter Kisfali

12Department of Medical Genetics, University of Pécs, 7624 Pécs, Hungary

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
MMMárton Mohás
Márton Mohás
PKPéter Kisfali
Péter Kisfali
LJLuca Járomi
Luca Járomi
AMAnita Maász
Anita Maász
EFEszter Fehér
Eszter Fehér
BMBela Melegh
Bela Melegh
Recent studies revealed that glucokinase regulatory protein (GCKR) variants (rs780094 and rs1260326) are associated with serum triglycerides and plasma glucose levels. Here we analyzed primarily the association of these two variants with the lipid profile and plasma glucose levels in Hungarian subjects with type 2 diabetes mellitus and metabolic syndrome; and also correlated the genotypes with the carotid intima-media thickness records.

1 June 2011 in Pediatric Obesity
Verified
Journal Article
Closed access
PDF file
KHKatalin Horvatovich
Katalin Horvatovich
SBSzilvia Bokor
Szilvia Bokor
ÁBÁkos Baráth
Ákos Baráth
AMAnita Maász
Anita Maász
PKPéter Kisfali
Péter Kisfali
BMBela Melegh
Bela Melegh
Apolipoprotein A5 (APOA5) gene variants have been shown to be associated with elevated TG levels; the T-1131C (rs662799) variant has been reported to confer risk for the metabolic syndrome in adult populations. Little is known about the APOA5 variants in pediatric population, no such information is available for pediatric obesity at all. Here we examined four haplotype-tagging polymorphisms (T-1131C, IVS3 + G476A [rs2072560], T1259C [rs2266788] and C56G [rs3135506]) and studied also the frequency of major naturally occurring haplotypes of APOA5 in obese children. The polymorphisms were analyzed in 232 obese children, and in 137 healthy, normal weight controls, using PCR-RFLP methods. In the pediatric patients we could confirm the already known adult subjects based association of -1131C, IVS3 + 476A and 1259C variants with elevated triglyceride concentrations, both in obese patients and in the controls. The prevalence of the APOA5*2 haplotype (containing the minor allele of T-1131C, IVS3 + G476A and T1259C SNPs together) was 15.5% in obese children, and 5.80% in the controls (p<0.001); multiple logistic regression analysis revealed that this haplotype confers susceptibility for development of obesity (OR=2.87; 95% CI: 1.29-6.37; p≤0.01). By contrast, the APOA5*4 haplotype (with -1131C alone) did not show similar associations. Our findings also suggest that the APOA5*5 haplotype (1259C alone) can be protective against obesity (OR=0.25; 95% CI: 0.07-0.80; p<0.05). While previous studies in adults demonstrated, that the APOA5 -1131C minor allele confers risk for adult metabolic syndrome, here we show, that the susceptibility nature of this SNP restricted to the APOA5*2 haplotype in pediatric obese subjects.

1 April 2009
Verified
Journal Article
Closed access
Krisztian BanyaiKrisztian Banyai
Krisztian Banyai
Vito MartellaVito Martella
Vito Martella
EMEdina Meleg
Edina Meleg
PKPéter Kisfali
Péter Kisfali
ZPZoltan Peterfi
Zoltan Peterfi
GSGyörgy Szucs
György Szucs

8 January 2014 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
APAlajos Pár
Alajos Pár
GPGabriella Par
Gabriella Par
ITIstván Dr. Tornai
István Dr. Tornai
FSFerenc Szalay
Ferenc Szalay
DVDalma Várszegi
Dalma Várszegi
BMBela Melegh
Bela Melegh
Previous studies have shown that single nucleotide polymorphisms (SNP) in IL28B and IL10R are associated with sustained virological response (SVR) in chronic hepatitis C patients treated with pegilated interferon plus ribavirin (P/R). The present study extends our earlier investigations on a large East-Central European cohort. The allele frequencies of IL28B and IL10R in genotype 1 HCV infection were compared with that of healthy controls for the purpose of examining the relationship between the polymorphisms and the SVR to P/R treatment.

1 June 2012 in Orvosi Hetilap
Verified
Journal Article
Closed access
PKPéter Kisfali
Péter Kisfali
BMBéla Melegh
Béla Melegh
Mutations of the frataxin gene give the most common underlying genetic background of recessively inheritable type ataxias in Europe. In our department, we have been establishing the molecular genetic diagnosis of Friedreich’s ataxia since 2001. We analyzed a total of 221 blood samples from the whole country. Methods: After fragment analysis we performed direct exon sequencing. Results: This study summarizes the retrospective analysis of these genetic test results. Pathological alteration was identified in altogether 26 cases. 2 expanded alleles were found in intron 1 in all 26 genetically confirmed patients; which is not more than 12% of the total analyzed samples. We did exon sequencing in the case of patients having one expanded allele and found no point mutation in any of the cases. Conclusions: In our setting, we could not verify the diagnosis by genetic analysis in a remarkable number of patients, which on one hand underlines the importance of clinical neurologic and clinical genetic analyses before performing tests, and on the other hand, it raises the need to examine the patients for other ataxia types. Orv. Hetil., 2012, 153, 852–855.